Key Highlights
•
A new cell culture-derived quadrivalent influenza vaccine (QIVc) was shown to be effective and safe in protecting infants and children against the flu across five seasons. This supports the use of this advanced vaccine technology to better protect young children, a group highly vulnerable to serious flu complications.
Source →
•
Researchers have integrated the concept of vaccine hesitancy into a classic health behavior model to better understand parental decisions about the new RSV vaccine for children. This work is crucial for designing more effective public health campaigns that address parents’ specific fears and concerns, potentially increasing vaccination rates.
Source →
•
A commentary highlights a major ethical and clinical problem: many pediatric home hospice programs in the U.S. require a “Do Not Resuscitate” (DNR) order before a child can receive care. This policy creates a significant barrier to compassionate end-of-life care for families who may not be ready to make that decision, forcing a choice between support and hope.
Source →
Stay curious. Stay informed — with
Science Briefing.
Always double check the original article for accuracy.
